PerspectiveSpecial considerations in the evaluation and management of uveitis in children☆
Section snippets
Patient populations
Children with uveitis actually represent a heterogeneous group of patients. Issues of importance vary with the age of the patient; among other factors, stages of growth and development, metabolism, cooperation, and exposures vary greatly between birth and adulthood. Subpopulations include neonates and infants; young children, during the period of risk for amblyopia; older children; and adolescents.
Examination may be difficult in very young patients, and in some cases, examination under
Differential diagnosis
As with adults, there are many causes of childhood uveitis, and a differential diagnosis depends on the region of the eye involved and the characteristics of disease. The distribution of cases between anatomic categories of disease (anterior, intermediate, posterior, and panuveitis) in children varies with age1, 3 and varies between reported series, in part because of a different spectrum of diseases seen in different geographic areas. Cunningham4 found that posterior uveitis was slightly more
Complications of disease
It is generally believed that children with uveitis are at greater risk than adults for development of complications,4 although there is no definitive proof of that. The higher prevalence of complications among children with uveitis may be attributable to longer delays before diagnosis and treatment or to the spectrum of diseases seen in children. Complications include band keratopathy, secondary glaucoma, posterior synechiae, secondary cataract formation, inflammatory membranes, macular edema,
Therapy
Traditionally, corticosteroids have been the mainstay of treatment for noninfectious forms of uveitis. In recent years, there has been a trend to earlier and more aggressive use of immunomodulatory agents for adults and children to treat noninfectious forms of uveitis, both to prevent development of complications and to avoid local and systemic side effects of corticosteroids. The more traditional approach of waiting until vision drops or complications develop before beginning immunomodulatory
Monitoring and compliance
Monitoring of disease and treatment effects is especially important in children with uveitis, who may not report changes in vision, as would an adult. Particular attention should be paid to visual acuity of children at risk for amblyopia. As with adults, periodic examinations should be performed to assess levels of inflammation (anterior chamber cells and flare; vitreous humor cells and haze), signs of uncontrolled inflammation (keratic precipitates; iris nodules), the presence of
Summary
The evaluation and management of children with uveitis is based on the same principles that apply to adults, with the caveat that there are additional special considerations when dealing with children. Examination and treatment are more challenging in young patients, and coordination of care with pediatricians experienced in the management of inflammatory diseases is important.14 Substantial progress has been made in this field over the past several decades, but even recent surveys demonstrate
Acknowledgements
Additional participants in the workshop “Evaluation and Management of Inflammatory Eye Disease in Children” included: Emmett T. Cunningham, Jr., MD, PhD, MPH (New York, NY), Janet L. Davis, MD (Miami, FL), Joseph L. Demer, MD, PhD (Los Angeles, CA), Sean P. Donahue, MD, PhD (Nashville, TN), Clive Edelsten, MRCP, FRCOphth (London, England), C. Stephen Foster, MD (Boston, MA), Lynn K. Gordon, MD, PhD (Los Angeles, CA), Elizabeth M. Graham, FRCP, DO, FRCOphth (London, England), Sherwin J.
References (80)
- et al.
Visual loss associated with pediatric uveitis in English primary and referral centers
Am J Ophthalmol
(2003) - et al.
Systemic uveitis syndromes in childhoodan analysis of 340 cases
Ophthalmology
(1984) - et al.
Changing patterns in uveitis of childhood
Ophthalmology
(1996) - et al.
Intermediate uveitis in childhood preceding the diagnosis of multiple sclerosisa 13-year follow-up
Am J Ophthalmol
(2003) - et al.
Arthritis and uveitis in childrena pediatric rheumatology perspective
Am J Ophthalmol
(2003) - et al.
Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program
Am J Ophthalmol
(2003) Juvenile arthritis and uveitis
Surv Ophthalmol
(1990)- et al.
Prognostic factors in the uveitis of juvenile rheumatoid arthritis
Ophthalmology
(1987) - et al.
Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis
Ophthalmology
(1997) - et al.
Occurrence of uveitis in recently diagnosed juvenile chronic arthritisa prospective study
Ophthalmology
(2001)
The prevalence of uveitis in juvenile rheumatoid arthritis
J AAPOS
Sarcoidosis in children
Curr Probl Pediatr
Pediatric ocular sarcoidosis
Surv Ophthalmol
Multifocal choroiditis in patients with familial juvenile systemic granulomatosis
Am J Ophthalmol
Lymphocytic choriomeningitis virusan underdiagnosed cause of congenital chorioretinitis
Am J Ophthalmol
Juvenile xanthogranuloma masquerading as pediatric chronic uveitisa clinicopathologic study
Surv Ophthalmol
Cataract development and cataract surgery in patients with juvenile rheumatoid arthritis-associated iridocyclitis
Ophthalmology
Laser flare photometry and complications of chronic uveitis in children
Am J Ophthalmol
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disordersrecommendations of an expert panel
Am J Ophthalmol
Uveitis as the only clinical manifestation of poststreptococcal syndrome
Am J Ophthalmol
Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis
J Pediatr
Cyclosporine therapy for severe sight-threatening uveitis in children and adolescents
Ophthalmology
Corticosteroids and growth
J Pediatr
Ocular-hypertensive response to topical steroids in children
Ophthalmology
Ocular hypertensive response to topical dexamethasone in childrena dose-dependent phenomenon
Ophthalmology
The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis
Am J Ophthalmol
Surgical management of cataracts in children with juvenile rheumatoid arthritis-associated uveitis
Am J Ophthalmol
Causes of reduced visual acuity on long-term follow-up after cataract extraction in patients with uveitis and juvenile rheumatoid arthritis
Am J Ophthalmol
Pars plana lensectomy and vitrectomy for complicated cataracts in juvenile rheumatoid arthritis
Ophthalmology
Intraocular lens implantation in patients with juvenile rheumatoid arthritis
Am J Ophthalmol
Cataract surgery in children with chronic uveitis
Ophthalmology
Intraocular lens implantation in patients with juvenile rheumatoid arthritis-associated uveitisan unresolved management issue
Am J Ophthalmol
When may the posterior capsule be preserved in pediatric intraocular lens surgery?
Ophthalmology
Goniotomy for glaucoma secondary to chronic childhood uveitis
Am J Ophthalmol
Trabeculodialysis for inflammatory glaucoma in children and young adults
Ophthalmology
Uveitis in childrenpopulation-based study in Finland
Acta Ophthalmol Scand
Epidemiology of uveitis
Arch Ophthalmol
Uveitis in children
Ocul Immunol Inflamm
Pattern of uveitis in children
Br J Ophthalmol
Posterior uveitis in the pediatric population
Int Ophthalmol Clin
Cited by (0)
- ☆
InternetAdvance publication at ajo.com March 24, 2003.
Doctor Holland was supported in part by Research to Prevent Blindness, Inc, New York, New York, the Skirball Foundation, Los Angeles, California, and the David May II Endowed Professorship, and is a recipient of a Research to Prevent Blindness Physician-Scientist Award.